Form C/A Mediloq, Inc.
- Wall Street closes with sharp gains as final quarter begins
- Tesla (TSLA) Now 'Unlikely' to Hit Its 50% Delivery Growth Goal for 2022 - Analyst
- U.S. manufacturing nearly brakes; price pressures abating
- Citi Cuts Year-end S&P 500 Price Target to 4000, Introduces 2023 PT of 3900
- Oil jumps about $4 as OPEC+ weighs biggest output cut since 2020
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
C/A 0001858449 XXXXXXXX 020-28811 LIVE false false false false On Page 38: 1- Changed "Company" to "Intermediary" in sentence to read "the Intermediary will notify purchasers....." 2- Changed cancellation from "before the Minimum Amount is reached" to "48-hour period prior to the offering deadline..." Mediloq, Inc. Corporation DE 10-12-2016 5546 SPINE RD UNIT 104 BOULDER CO 80301 https://www.mediloq.com/ N IGNITE SOCIAL IMPACT INC. 0001810362 007-00237 310501 7.0% of the amount raised Common Stock 8000 1.25000 10000.00 Y Other At company's discretion 1070000.00 09-30-2022 0.00 55363.00 52759.00 2981.00 1154.00 0.00 0.00 58724.00 57409.00 126615.00 79542.00 39091.00 54330.00 52211.00 63831.00 0.00 0.00 -45784.00 -39237.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Mediloq, Inc. Daniel Estoque CEO Daniel Estoque CEO 08-16-2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caldwell Acquires The Counsel Network
- Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
- RAC Deploys Earnix Suite to Unlock Efficiencies and Innovation
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!